---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-026867"
form_type: "8-K"
ticker: "SHPH"
cik: "0001757499"
company_name: "Shuttle Pharmaceuticals Holdings, Inc."
filed_at: "2025-09-08T23:59:59+00:00"
generated_at: "2026-05-17T07:40:18.445681+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Adam Chambers appointed to board of Shuttle Pharmaceuticals; principal of Bowery Consulting

## Summary
- Appointment effective September 8, 2025; no family relationships with other directors/officers.
- Chambers is principal of Bowery Consulting, lender under revolving loan (Feb 28, 2025) and consulting services (Mar 21, 2025).
- No other material interests in transactions required to be disclosed under Item 404(a).
- No arrangements or understandings under which he was appointed.

## SEC filing metadata
- accession: 0001641172-25-026867
- form_type: 8-K
- ticker: SHPH
- cik: 0001757499
- company_name: Shuttle Pharmaceuticals Holdings, Inc.
- filed_at: 2025-09-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1757499/000164117225026867/0001641172-25-026867-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1757499/000164117225026867/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-026867
- JSON: https://secwatch.observer/filing/0001641172-25-026867.json
- Plain text: https://secwatch.observer/filing/0001641172-25-026867.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.